Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1122 participants
OBSERVATIONAL
2021-08-12
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.
NCT04270032
Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
NCT03851497
Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography
NCT03708978
Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer
NCT06546072
Artificial Intelligence in Mammography-Based Breast Cancer Screening
NCT04156880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Artificial intelligence (AI) is a new method emerging in recent years, active in many medical fields and can effectively improve the diagnostic efficiency. However, previous researches on the application of AI in ultrasound are focused on single or multi-modality static ultrasound images. This multi-center study intends to evaluate the value of the detection and differential diagnosis of breast mass using deep learning AI-based real-time ultrasound examination.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yizhun BUSMS
During the breast scanning, Yizhun BUSMS uses different color box to identify the breast lesion, and the box color indicates the risk grade of the lesion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The breast lesion that will obtain definite pathological diagnosis or follow-up at least two years.
Exclusion Criteria
2. The breast cancer patient who has received neoadjuvant chemotherapy.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Peking University Cancer Hospital & Institute
OTHER
Peking University Third Hospital
OTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
Third Affiliated Hospital of Zhengzhou University
OTHER
Hebei Medical University Fourth Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Shanxi Province Cancer Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Chongqing University Cancer Hospital
OTHER
Anqing Hospital affiliated to Anhui Medical University
UNKNOWN
Qinhuangdao Maternal and Child Health Care Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
Anyang Tumor Hospital
OTHER
The Third Affiliated Hospital of Jinzhou Medical University
UNKNOWN
General Hospital of Jincheng Coal Industry Group
UNKNOWN
Suzhou First People's Hospital
UNKNOWN
Peking University
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yong Wang
Role: PRINCIPAL_INVESTIGATOR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC2962
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.